Angela Dispenzieri, MD | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to People / Healthcare Professionals
Angela Dispenzieri, MD

Angela Dispenzieri, MD

Healthcare Professional
Chair
Division of Hematology
Mayo Clinic
200 First St. SW
Rochester, Minnesota, United States

Angela Dispenzieri is a Chair of Hematology Research at the Mayo Clinic, Rochester, Minnesota. She is the immediate past president of the International Society of Amyloidosis. She chairs the Amyloid Interest Group at the Mayo Clinic. She also developed the first internationally recognized AL amyloidosis staging system in 2004.

Dr. Dispenzieri completed her graduation from Massachusetts Institute of Technology in 1985. She then pursued her MD from Albert Einstein College of Medicine in 1991 and completed her Residency and Fellowship from Mayo Clinic College of Medicine. 

Dr. Angela Dispenzieri has an experience in treating conditions like amyloidosis, cryoglobulinemia, monoclonal gammopathy of undetermined significance, multiple myeloma, osteosclerotic myeloma and POEMS syndrome.

Dr. Dispenzieri is associated with various departments and programs in the hospital including Transplant Center, Bone Marrow Transplant Program, Hematology Department, and Cancer Center.

 

Representative Publications:

Association of Patisiran, an RNA Interference Therapeutic, With Regional Left Ventricular Myocardial Strain in Hereditary Transthyretin Amyloidosis: The APOLLO Study

Natural history of multiple myeloma with de novo del (17p) 

Two types of amyloidosis presenting in a single patient: A case series 

Clinical features, laboratory characteristics and outcomes of patients with renal versus cardiac light chain amyloidosis 

A Modern Primer on Light Chain Amyloidosis in 592 Patients With Mass Spectrometry-Verified Typing

view profile

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2024 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close